Eaton Vance Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $57.3M | Sell |
484,689
-461
| -0.1% | -$54.5K | 0.09% | 228 |
|
|
2022
Q2 | $69.3M | Buy |
485,150
+15,271
| +3% | +$2.18M | 0.1% | 211 |
|
|
2022
Q1 | $80.9M | Buy |
469,879
+45,715
| +11% | +$7.87M | 0.09% | 211 |
|
|
2021
Q4 | $108M | Sell |
424,164
-3,361
| -0.8% | -$854K | 0.13% | 153 |
|
|
2021
Q3 | $163M | Buy |
427,525
+47,649
| +13% | +$18.2M | 0.23% | 97 |
|
|
2021
Q2 | $89.3M | Sell |
379,876
-1,211
| -0.3% | -$285K | 0.12% | 178 |
|
|
2021
Q1 | $49.9M | Buy |
381,087
+373,539
| +4,949% | +$48.9M | 0.07% | 264 |
|
|
2020
Q4 | $789K | Buy |
+7,548
| New | +$789K | ﹤0.01% | 1138 |
|